House Panel Amends, Advances FDA User Fee Bill

A bill to reauthorize FDA user fees for the next five years received voice-vote approval from a House health subcommittee Thursday. The measure now heads to the full Energy and Commerce Committee for consideration.
Source: Drug Industry Daily